Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector




















Sort by: Date|Relevance

Where’s the Bottom? – Cycles Paint A Clear Picture

Has the selloff ended? When will it end? What will the bottom look like and am I at risk of taking further losses? What should I do? Do you want to take a guess at how many of our friends and family members are calling us over the past week or so asking these questions? Pe...

Clinical Program Started for Agitation with Schizophrenia, Bipolar Disorder

The design of and an opinion on the included studies are provided in an H.C. Wainwright & Co. report. In a Dec. 30 research note, H.C. Wainwright & Co. analyst Ram Selvaraju reported that BioXcel Therapeutics Inc. (BTAI:NASDAQ) launched its pivotal trial program for...

NASDAQ Set to Fall 1000pts In Early 2020, and What it Means for Gold

One of our most interesting predictive modeling system is the Adaptive Dynamic Learning (ADL) price modeling system. It is capable of learning from past price data, building price DNA chains and attempting to predict future price activity with a fairly high degree of accuracy....

The Revolutionary Co. That’s Breaking Through the Blood Brain Barrier

(Click image to play video) Delivery of therapeutics across the blood-brain barrier (BBB) and into the brain has been the single greatest challenge to treating hundreds of common and rare neurological diseases, including brain cancers, neurodegenerative diseases...

Analyst: Biotech to Have 'Eventful Year' with Data Readouts in Three Indications

This California company expects results from clinical trials in liver disease and psoriasis in 2019. In a March 8 research note, H.C. Wainwright & Co. analyst Ed Arce reported that DURECT Corp. (DRRX:NASDAQ) continues advancing clinical trials evaluating its lead prod...

Three Prospect Generators Have Exciting Year Ahead

Midland Exploration Inc. (MD:TSX.V, 1.30) reported an early-stage copper-gold-molybdenum discovery in James Bay based on grab samples taken just prior to the end of the exploration season. Now, following soil testing and an IP geophysical survey at the 100%-owned Mythr...

Gold Miners Are Finally Making Some Interesting Capital Investments

Last week I was pleased to attend the Prospectors & Developers Association of Canada (PDAC) conference in Toronto. PDAC is one of the largest mining conferences in the world. More than 25,000 people turned out this year, many of them selling equipment services, exhibitin...

Diamonds in Finland: Searching for the Leader of the Wolf Pack

Arctic Star Exploration Corp. is on fire. The European diamond hunter has been trading record volumes recently while cashing up for the next round of an eagerly-awaited exploration program at its 100% owned Timantti Project in Finland. Finding diamonds is one of...

The Notre Dame Fire: Lessons for Gold Investors

The Monday’s fire of Notre Dame Cathedral shocked the world. Since then, the French, the Catholics, and the architecture and art lovers hadn’t been talking about anything else. The precious metals community was less disturbed – even though it tu...

Galapagos Agrees to $3.95 Billion, 10-Year Licensing Deal Plus $1.1 Billion Investment from Gilead

Galapagos announced that Gilead Sciences has agreed to pay $3.95 billion for a 10-year partnership and licensing deal and will invest an additional $1.1 billion in newly issued shares of the company. Galapagos NV (GLPG:NASDAQ; GLPG:BSE) ADR shares opened up over 1...
1 2 3 4